Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 3
1953 1
1956 1
1960 1
1965 1
1979 1
1984 1
1987 3
1988 3
1990 4
1991 5
1992 9
1993 8
1994 8
1995 2
1996 13
1997 4
1998 9
1999 8
2000 9
2001 11
2002 12
2003 11
2004 10
2005 8
2006 7
2007 10
2008 6
2009 1
2010 2
2012 1
2014 4
2015 1
2016 7
2017 14
2018 9
2019 22
2020 12
2021 10
2022 3
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

243 results

Results by year

Filters applied: . Clear all
Page 1
Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.
Papi A, Chipps BE, Beasley R, Panettieri RA Jr, Israel E, Cooper M, Dunsire L, Jeynes-Ellis A, Johnsson E, Rees R, Cappelletti C, Albers FC. Papi A, et al. Among authors: albers fc. N Engl J Med. 2022 Jun 2;386(22):2071-2083. doi: 10.1056/NEJMoa2203163. Epub 2022 May 15. N Engl J Med. 2022. PMID: 35569035 Clinical Trial.
Mobile Apps for Medication Management: Review and Analysis.
Tabi K, Randhawa AS, Choi F, Mithani Z, Albers F, Schnieder M, Nikoo M, Vigo D, Jang K, Demlova R, Krausz M. Tabi K, et al. Among authors: albers f. JMIR Mhealth Uhealth. 2019 Sep 11;7(9):e13608. doi: 10.2196/13608. JMIR Mhealth Uhealth. 2019. PMID: 31512580 Free PMC article. Review.
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease.
Pavord ID, Chanez P, Criner GJ, Kerstjens HAM, Korn S, Lugogo N, Martinot JB, Sagara H, Albers FC, Bradford ES, Harris SS, Mayer B, Rubin DB, Yancey SW, Sciurba FC. Pavord ID, et al. Among authors: albers fc. N Engl J Med. 2017 Oct 26;377(17):1613-1629. doi: 10.1056/NEJMoa1708208. Epub 2017 Sep 11. N Engl J Med. 2017. PMID: 28893134 Free article. Clinical Trial.
Albuterol-Budesonide Pressurized Metered Dose Inhaler in Patients With Mild-to-Moderate Asthma: Results of the DENALI Double-Blind Randomized Controlled Trial.
Chipps BE, Israel E, Beasley R, Panettieri RA Jr, Albers FC, Rees R, Dunsire L, Danilewicz A, Johnsson E, Cappelletti C, Papi A. Chipps BE, et al. Among authors: albers fc. Chest. 2023 Sep;164(3):585-595. doi: 10.1016/j.chest.2023.03.035. Epub 2023 Mar 30. Chest. 2023. PMID: 37003355 Free article. Clinical Trial.
Sexual and reproductive health literacy of school adolescents in Lao PDR.
Vongxay V, Albers F, Thongmixay S, Thongsombath M, Broerse JEW, Sychareun V, Essink DR. Vongxay V, et al. Among authors: albers f. PLoS One. 2019 Jan 16;14(1):e0209675. doi: 10.1371/journal.pone.0209675. eCollection 2019. PLoS One. 2019. PMID: 30650100 Free PMC article.
Efficacy and safety of as-needed albuterol/budesonide versus albuterol in adults and children aged ≥4 years with moderate-to-severe asthma: rationale and design of the randomised, double-blind, active-controlled MANDALA study.
Chipps BE, Albers FC, Reilly L, Johnsson E, Cappelletti C, Papi A. Chipps BE, et al. Among authors: albers fc. BMJ Open Respir Res. 2021 Dec;8(1):e001077. doi: 10.1136/bmjresp-2021-001077. BMJ Open Respir Res. 2021. PMID: 34887317 Free PMC article. Clinical Trial.
Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma.
Khatri S, Moore W, Gibson PG, Leigh R, Bourdin A, Maspero J, Barros M, Buhl R, Howarth P, Albers FC, Bradford ES, Gilson M, Price RG, Yancey SW, Ortega H. Khatri S, et al. Among authors: albers fc. J Allergy Clin Immunol. 2019 May;143(5):1742-1751.e7. doi: 10.1016/j.jaci.2018.09.033. Epub 2018 Oct 23. J Allergy Clin Immunol. 2019. PMID: 30359681 Free article. Clinical Trial.
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial.
Chupp GL, Bradford ES, Albers FC, Bratton DJ, Wang-Jairaj J, Nelsen LM, Trevor JL, Magnan A, Ten Brinke A. Chupp GL, et al. Among authors: albers fc. Lancet Respir Med. 2017 May;5(5):390-400. doi: 10.1016/S2213-2600(17)30125-X. Epub 2017 Apr 5. Lancet Respir Med. 2017. PMID: 28395936 Clinical Trial.
Biomarkers for severe eosinophilic asthma.
Yancey SW, Keene ON, Albers FC, Ortega H, Bates S, Bleecker ER, Pavord I. Yancey SW, et al. Among authors: albers fc. J Allergy Clin Immunol. 2017 Dec;140(6):1509-1518. doi: 10.1016/j.jaci.2017.10.005. J Allergy Clin Immunol. 2017. PMID: 29221581 Free article. Review.
243 results